Press Release
Doctor Pleads Guilty To Unlawful Drug Distribution, False Statement To Medicare, And Paycheck Protection Program Fraud
For Immediate Release
U.S. Attorney's Office, Middle District of Florida
Tampa, FL – United States Attorney Roger B. Handberg announces that Tommy Louisville (71, Pembroke Pines) has pleaded guilty to unlawful drug distribution, making a false statement related to health care matters, and wire fraud. Louisville faces a maximum penalty of 10 years in federal prison for the drug distribution offense, up to 5 years’ imprisonment for the false statement offense, and up to 20 years in federal prison for the wire fraud offense. A sentencing date has not been scheduled.
According to the plea agreement, Louisville was a Florida-licensed physician and Drug Enforcement Administration (DEA) registrant. On May 30, 2019, the Florida Board of Medicine suspended Louisville from the practice of medicine for two years, thereby making him ineligible to lawfully prescribe controlled substances. Louisville continued to issue controlled-substance prescriptions after his medical license was suspended. Furthermore, he concealed from Medicare the fact that he was not authorized to issue prescriptions in connection with the submission to Medicare of the prescriptions for payment. Louisville eventually shuttered his medical business in approximately November 2019.
Between April and May 2020, Louisville used his closed business to fraudulently obtain a federal Paycheck Protection Program (PPP) loan in the amount of $33,034. Louisville submitted an application that contained multiple fraudulent representations, including stating average monthly payroll suggesting he actively operated a medical business; that he employed six employees; and certifying that loan proceeds would be used for business-related purposes. Louisville agreed to forfeit $33,034, the proceeds of his criminal conduct.
In May 2021, the Attorney General established the COVID-19 Fraud Enforcement Task Force to marshal the resources of the Department of Justice in partnership with agencies across government to enhance efforts to combat and prevent pandemic-related fraud. The task force bolsters efforts to investigate and prosecute the most culpable domestic and international criminal actors and assists agencies tasked with administering relief programs to prevent fraud by augmenting and incorporating existing coordination mechanisms, identifying resources and techniques to uncover fraudulent actors and their schemes, and sharing and harnessing information and insights gained from prior enforcement efforts.
This case was investigated by the U.S. Department of Health and Human Services - Office of Inspector General, the Drug Enforcement Administration -Tampa District Office, and the Federal Bureau of Investigation. It is being prosecuted by Assistant United States Attorney Greg Pizzo.
Anyone with information about allegations of attempted fraud involving COVID-19 can report it by calling the Justice Department’s National Center for Disaster Fraud (NCDF) Hotline at 866-720-5721 or via the NCDF Web Complaint Form at www.justice.gov/disaster-fraud/ncdf-disaster-complaint-form.
Updated November 6, 2023
Topics
Coronavirus
Disaster Fraud
Drug Trafficking
Prescription Drugs
Financial Fraud
Health Care Fraud
Component